FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2626540521> ?p ?o ?g. }

• W2626540521 endingPage "52" @default.
• W2626540521 startingPage "46" @default.
• W2626540521 abstract "Aim. To summarize the experience of a multidisciplinary therapy hospital in treating patients with hepatitis C virus (HCV)-associated cryoglobulinemic vasculitis (CV). Subjects and methods. Seventy-two patients (mean age, 49.4±10.3 years) with HCV-associated CV were examined and followed up for an average period of 2.8±3.6 years. The efficiency of traditional (corticosteroids ± cyclophosphamide) and selective (rituximab) immunosuppressive therapy (IST) was estimated in 31 and 15 observations, respectively, and that of antiviral therapy (AVT) in 25. Vasculitis activity was assessed using the Birmingham vasculitis activity score (BVAS). The patients’ survival was studied; multivariate logistic regression analysis was carried out. Results. 24 (33.4%) of the 72 patients had a stage of liver cirrhosis (LC). The pretreatment mean BVAS was 11.9±7.2 (range 2 to 36). Severe CV (BVAS ≥15) was present in 30.6% of the patients. AVT was accompanied by achievement of sustained virologic response in 48% of the patients, clinical remission in 68% and had an advantage over IST in relation to long-term treatment results. Rituximab was significantly more effective than traditional immunosuppressants (remission rates of 73 and 13%, respectively). Combined therapy (rituximab and AVT) was most effective in patients with severe forms of vasculitis. Sixteen patients died from complications of vasculitis (37.5%), infection (37.5%), and LC (25%). The factors adversely affecting prognosis were age >55 years (odds ratio (OR), 4.49), the presence of LC (OR, 3.68), renal failure (OR, 4.66) and the use of glucocorticosteroids (OR, 3.91). Conclusion. HCV-associated CV can determine the prognosis of chronic HСV infection. AVT is the treatment of choice in all patients with HСV-associated CV. AVT must be combined with rituximab therapy in patients with severe forms of vasculitis." @default.
• W2626540521 created "2017-06-23" @default.
• W2626540521 creator A5009125671 @default.
• W2626540521 creator A5027072551 @default.
• W2626540521 creator A5027091212 @default.
• W2626540521 creator A5040170197 @default.
• W2626540521 creator A5047173506 @default.
• W2626540521 creator A5059197008 @default.
• W2626540521 creator A5070498844 @default.
• W2626540521 creator A5075291120 @default.
• W2626540521 creator A5078377003 @default.
• W2626540521 date "2017-05-15" @default.
• W2626540521 modified "2023-10-01" @default.
• W2626540521 title "Hepatitis C virus-associated cryoglobulinemic vasculitis: A 20-year experience with treatment" @default.
• W2626540521 cites W1518558996 @default.
• W2626540521 cites W1983621878 @default.
• W2626540521 cites W1988512834 @default.
• W2626540521 cites W1997745788 @default.
• W2626540521 cites W2016553185 @default.
• W2626540521 cites W2019985783 @default.
• W2626540521 cites W2025338109 @default.
• W2626540521 cites W2044784043 @default.
• W2626540521 cites W2064650635 @default.
• W2626540521 cites W2090887217 @default.
• W2626540521 cites W2093097715 @default.
• W2626540521 cites W2110493572 @default.
• W2626540521 cites W2111559593 @default.
• W2626540521 cites W2112234313 @default.
• W2626540521 cites W2114965058 @default.
• W2626540521 cites W2117786286 @default.
• W2626540521 cites W2120070988 @default.
• W2626540521 cites W2120427700 @default.
• W2626540521 cites W2128969304 @default.
• W2626540521 cites W2165542457 @default.
• W2626540521 cites W2210494829 @default.
• W2626540521 cites W2217275225 @default.
• W2626540521 cites W2419660559 @default.
• W2626540521 cites W411495898 @default.
• W2626540521 cites W4247261611 @default.
• W2626540521 doi "https://doi.org/10.17116/terarkh201789546-52" @default.
• W2626540521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28631698" @default.
• W2626540521 hasPublicationYear "2017" @default.
• W2626540521 type Work @default.
• W2626540521 sameAs 2626540521 @default.
• W2626540521 citedByCount "12" @default.
• W2626540521 countsByYear W26265405212018 @default.
• W2626540521 countsByYear W26265405212019 @default.
• W2626540521 countsByYear W26265405212020 @default.
• W2626540521 countsByYear W26265405212021 @default.
• W2626540521 countsByYear W26265405212022 @default.
• W2626540521 countsByYear W26265405212023 @default.
• W2626540521 crossrefType "journal-article" @default.
• W2626540521 hasAuthorship W2626540521A5009125671 @default.
• W2626540521 hasAuthorship W2626540521A5027072551 @default.
• W2626540521 hasAuthorship W2626540521A5027091212 @default.
• W2626540521 hasAuthorship W2626540521A5040170197 @default.
• W2626540521 hasAuthorship W2626540521A5047173506 @default.
• W2626540521 hasAuthorship W2626540521A5059197008 @default.
• W2626540521 hasAuthorship W2626540521A5070498844 @default.
• W2626540521 hasAuthorship W2626540521A5075291120 @default.
• W2626540521 hasAuthorship W2626540521A5078377003 @default.
• W2626540521 hasBestOaLocation W26265405211 @default.
• W2626540521 hasConcept C126322002 @default.
• W2626540521 hasConcept C156957248 @default.
• W2626540521 hasConcept C203014093 @default.
• W2626540521 hasConcept C2522874641 @default.
• W2626540521 hasConcept C2776015282 @default.
• W2626540521 hasConcept C2776408679 @default.
• W2626540521 hasConcept C2776455275 @default.
• W2626540521 hasConcept C2776694085 @default.
• W2626540521 hasConcept C2776755627 @default.
• W2626540521 hasConcept C2777374719 @default.
• W2626540521 hasConcept C2779134260 @default.
• W2626540521 hasConcept C2779338263 @default.
• W2626540521 hasConcept C2780653079 @default.
• W2626540521 hasConcept C71924100 @default.
• W2626540521 hasConcept C90924648 @default.
• W2626540521 hasConceptScore W2626540521C126322002 @default.
• W2626540521 hasConceptScore W2626540521C156957248 @default.
• W2626540521 hasConceptScore W2626540521C203014093 @default.
• W2626540521 hasConceptScore W2626540521C2522874641 @default.
• W2626540521 hasConceptScore W2626540521C2776015282 @default.
• W2626540521 hasConceptScore W2626540521C2776408679 @default.
• W2626540521 hasConceptScore W2626540521C2776455275 @default.
• W2626540521 hasConceptScore W2626540521C2776694085 @default.
• W2626540521 hasConceptScore W2626540521C2776755627 @default.
• W2626540521 hasConceptScore W2626540521C2777374719 @default.
• W2626540521 hasConceptScore W2626540521C2779134260 @default.
• W2626540521 hasConceptScore W2626540521C2779338263 @default.
• W2626540521 hasConceptScore W2626540521C2780653079 @default.
• W2626540521 hasConceptScore W2626540521C71924100 @default.
• W2626540521 hasConceptScore W2626540521C90924648 @default.
• W2626540521 hasIssue "5" @default.
• W2626540521 hasLocation W26265405211 @default.
• W2626540521 hasLocation W26265405212 @default.
• W2626540521 hasOpenAccess W2626540521 @default.
• W2626540521 hasPrimaryLocation W26265405211 @default.
• W2626540521 hasRelatedWork W1983621878 @default.

• next